The data suggest TRPV1 and TRPV4 play important roles mediating the intracellular Ca2+ increase that drives critical functions such as associated proliferative and secretory responses of synoviocytes during joint inflammation thus promoting TRPV1 and TRPV4 as attractive potential therapeutic targets. The gene discussed is TRPV1; the disease is Arthritis.